Literature DB >> 15139014

Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia.

Yukiko Hagino1, Yukihiro Kariura, Yoshimasa Manago, Taiju Amano, Bing Wang, Masayuki Sekiguchi, Kaori Nishikawa, Shunsuke Aoki, Keiji Wada, Mami Noda.   

Abstract

alpha-amino-hydroxy-5-methyl-isoxazole-4-propionate (AMPA) receptor in rat cultured microglia were analyzed precisely using flop- and flip-preferring allosteric modulators of AMPA receptors, 4-[2-(phenylsulfonylamino)ethylthio]-2,6-difluoro-phenoxyacetamide (PEPA) and cyclothiazide (CTZ), respectively. Glutamate (Glu)- or kainite (KA)-induced currents were completely inhibited by a specific blocker of AMPA receptor, LY300164, indicating that functional Glu-receptors in cultured microglia are mostly AMPA receptor but not KA receptor in many cells. Glu- and KA-induced currents were potentiated by PEPA and CTZ in a concentration-dependent manner. The ratio of the potentiation by PEPA to the potentiation by cyclothiazide varied with cells between 0.1 and 0.9, suggesting cell-to-cell heterogeneity of AMPA receptor subunits expressed in microglia. Quantitative RT-PCR revealed that GluR1-3 mainly occurred in the flip forms, which agreed with the stronger potentiation of receptor currents by CTZ vs. PEPA. Finally, the potentiation of microglial AMPA receptors by PEPA and CTZ inhibited the Glu-induced release of tumor necrosis factor-alpha (TNF-alpha) unpredictably. The increase in TNF-alpha release by Glu or KA required extracellular Na+ and Ca2+ ions but not mitogen-activated protein kinase (MAPK), suggesting the effects of PEPA and CTZ were not due to the inhibition of MAPK. These results suggest that potentiation of microglial AMPA receptors serves as a negative feedback mechanism for the regulation of TNF-alpha release and may contribute to the ameliorating effects of allosteric modulators of AMPA receptors. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15139014     DOI: 10.1002/glia.20034

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  20 in total

Review 1.  Regulation of microglia by ionotropic glutamatergic and GABAergic neurotransmission.

Authors:  Wai T Wong; Minhua Wang; Wei Li
Journal:  Neuron Glia Biol       Date:  2011-12-14

Review 2.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

Review 3.  HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.

Authors:  Kurt F Hauser; Nazira El-Hage; Anne Stiene-Martin; William F Maragos; Avindra Nath; Yuri Persidsky; David J Volsky; Pamela E Knapp
Journal:  J Neurochem       Date:  2006-12-01       Impact factor: 5.372

Review 4.  Glial modulators as potential treatments of psychostimulant abuse.

Authors:  Patrick M Beardsley; Kurt F Hauser
Journal:  Adv Pharmacol       Date:  2014

Review 5.  The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Rebecca A Sosa; Thomas G Forsthuber
Journal:  J Interferon Cytokine Res       Date:  2011-09-15       Impact factor: 2.607

Review 6.  Microglia Function in the Central Nervous System During Health and Neurodegeneration.

Authors:  Marco Colonna; Oleg Butovsky
Journal:  Annu Rev Immunol       Date:  2017-02-09       Impact factor: 28.527

Review 7.  Regulation of the Neurodegenerative Process Associated to Parkinson's Disease by CD4+ T-cells.

Authors:  Hugo González; Francisco Contreras; Rodrigo Pacheco
Journal:  J Neuroimmune Pharmacol       Date:  2015-05-28       Impact factor: 4.147

8.  Complement 3a receptor in dorsal horn microglia mediates pronociceptive neuropeptide signaling.

Authors:  Suzanne Doolen; Jennifer Cook; Maureen Riedl; Kelley Kitto; Shinichi Kohsaka; Christopher N Honda; Carolyn A Fairbanks; Bradley K Taylor; Lucy Vulchanova
Journal:  Glia       Date:  2017-08-29       Impact factor: 7.452

Review 9.  Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.

Authors:  Kurt F Hauser; Pamela E Knapp
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

10.  NBQX, a highly selective competitive antagonist of AMPA and KA ionotropic glutamate receptors, increases seizures and mortality following picornavirus infection.

Authors:  Jane E Libbey; Tyler J Hanak; Daniel J Doty; Karen S Wilcox; Robert S Fujinami
Journal:  Exp Neurol       Date:  2016-04-09       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.